Semi-annual Performance Forecast for 2026
Filed with SSE · · 2 pages · Chinese
On 6ix: 6ix.com/news/zhejiang-huakang-pharmaceutical-co-ltdsemi-annual-performance-forecast-for-2026
Zhejiang Huakang Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhejiang Huakang Pharmaceutical
- Announcement on Conversion Result of Convertible Bonds and Share Changes
- Announcement on Addition of Implementing Entities for Projects Funded by the Convertible Corporate Bond Issued to Non-specific Objects
- Announcement on Adjusting the Total Cash Dividends for the 2025 Annual Profit Distribution
- Announcement on Abnormal Fluctuations in Stock Trading
- Indicative Announcement on Stopping Conversion of "Huakang Convertible Bonds" when Implementing 2025 Annual Dividend Distribution
Later from Zhejiang Huakang Pharmaceutical
- Announcement on Not Revising Downward the Conversion Price of "Huakang Convertible Bonds"
- Announcement on the Implementation of the Repurchase and Cancellation of Certain Restricted Shares under the Equity Incentive Plan
- Announcement on Resolutions of the 4th Meeting of the 7th Board of Directors
- Announcement on Completion of Repurchase and Cancellation of Certain Restricted Shares and Adjustment to the Conversion Price of "Huakang Convertible Bonds"
- Announcement on Progress in Providing Guarantee Limit for Wholly-owned Subsidiary
Follow Zhejiang Huakang Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Huakang Pharmaceutical